...
首页> 外文期刊>Gastroenterology research and practice >Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitiss A Meta- Analysis
【24h】

Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitiss A Meta- Analysis

机译:熊去氧胆酸和糖皮质激素联合治疗原发性胆汁性肝硬化伴自身免疫性肝炎的Meta分析

获取原文
获取原文并翻译 | 示例
           

摘要

Primary biliary cirrhosis (PBC) and autoimmune hepatitis (AIH) are two autoimmune diseases that have major effects on the liver. Each disease has its own clinical manifestations and immunological and histological features [1]. However, some patients may display the characteristics of both diseases. For example, patients with PBC with features of AIH have the characteristics of both PBC and AIH simultaneously [2]. According to the study by Czaja [3], the incidence of PBC-AIH in autoimmune liver disease is 7%. Chazouilleres et al. [4] concluded that the incidence of PBC-AIH in PBC is 9.2%.
机译:原发性胆汁性肝硬化(PBC)和自身免疫性肝炎(AIH)是对肝脏有重大影响的两种自身免疫性疾病。每种疾病都有其自身的临床表现以及免疫学和组织学特征[1]。但是,有些患者可能同时表现出两种疾病的特征。例如,具有AIH特征的PBC患者同时具有PBC和AIH的特征[2]。根据Czaja的研究[3],PBC-AIH在自身免疫性肝病中的发生率为7%。 Chazouilleres等。 [4]得出的结论是,PBC中PBC-AIH的发生率为9.2%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号